| JYHB2400183 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-04-26 | | | | | view |
| CYHB2450128 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| CYHB2450129 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| CYHB2450127 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-02-19 | | ZHONGFU Pharmaceutical Co Ltd | | | view |
| CYHB2301246 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-06-01 | | | | | view |
| JTH2200238 | 拉米夫定齐多夫定片 | lamivudine;zidovudine | Tablet | Chemical Drugs | Disposable Import Drug Application | 2022-12-21 | | | | | view |
| CYHB2250304 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(原6) | Supplementary Application | 2022-06-01 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
| JYHZ2200095 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | License Renew | 2022-04-07 | | | | | view |
| JYHB2101631 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-12-31 | | | | | view |
| JYHB2002510 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2020-12-07 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-12-16 | view |
| JYHB2002139 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2020-10-27 | 诺思格（北京）医药科技股份有限公司 | R&G PharmaStudies Co Ltd | Filed | 2020-11-09 | view |
| CYHS2000490 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(4) | Generic Drug | 2020-07-09 | 辰欣药业股份有限公司 | Cisen Pharmaceutical Co Ltd | Certificate Issued | 2021-09-13 | view |
| JYHB2000198 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2020-03-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-06-19 | view |
| CYHB1940054 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2019-11-27 | 安徽贝克生物制药有限公司 | Anhui Biochem Bio-Pharmaceutical Co Ltd | Certificate Issued | 2020-06-17 | view |
| JXHS1900147 | 多替拉韦拉米夫定片 | dolutegravir;lamivudine | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-11-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-04 | view |
| CYHS1900663 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(4) | Generic Drug | 2019-09-30 | 天地恒一制药股份有限公司 | Hinye Pharmaceutical Co Ltd | Certificate Issued | 2020-12-23 | view |
| CYHB1904247 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2019-08-06 | 石家庄龙泽制药股份有限公司 | Shijiazhuang Lonzeal Pharmaceuticals Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYHB1904246 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2019-08-06 | 石家庄龙泽制药股份有限公司 | Shijiazhuang Lonzeal Pharmaceuticals Co Ltd | Certificate Issued | 2019-08-27 | view |
| JXHL1900120 | 多替拉韦拉米夫定片 | dolutegravir;lamivudine | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-06-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2019-06-01 | view |
| CYHS1900120 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs(4) | Generic Drug | 2019-02-25 | 郑州泰丰制药有限公司 | Zhengzhou Taifeng Pharmaceutical Co Ltd | In Review | 2019-02-22 | view |
